Drug company is censured for offering perks to prescribing nursesBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7498.984-c (Published 28 April 2005) Cite this as: BMJ 2005;330:984
- Zosia Kmietowicz
The drug company AstraZeneca has been censured by the UK drug industry's watchdog for offering nurses excessive hospitality at educational meetings located in luxury hotels.
The watchdog, the Prescription Medicines Code of Practice Authority, ruled that one of the meetings had breached clause 2 of the code of practice, which says that methods of promotion must never bring discredit on or reduce confidence in the pharmaceutical …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial